Article

The incidence of all organ malignancies and overall survival of patient with sustained virological response of HCV

2022-12-21

Abstract excerpt

<title>Abstract</title> <p>Objective This study prospectively observed the incidence of all malignancies and the prognosis of all patients in a population of patients who achieved Sustained Virological Response (SVR) with a 100% capture rate. <h4>Design:</h4> A prospective study of 651 SVR cases was conducted from July 2013 to December 2021. The primary endpoint was the occurrence of all malignancies, and the se...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dc1691e7-b37e-5253-b904-46606fecfa9a
DOI: 10.21203/rs.3.rs-2364089/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The incidence of all organ malignancies and overall survival of patient with sustained virological response of HCVDOI 10.21203/rs.3.rs-2364089/v1Read

Causes of Death in Hepatocellular Carcinoma Patients: A SEER-Based StudySemantic proximity Read

Cause-Specific Mortality Following Sustained Virologic Response in hepatitis C patients Treated with Direct-Acting Antivirals: A Standardized Mortality Ratio AnalysisSemantic proximity Read

Impact of Egypt’s Hepatitis C Elimination Program on Liver Cancer Burden with Projections to 2050Semantic proximity Read

Effect of sustained viral clearance on liver-related mortality among individuals living with hepatitis C by treatment era: a population-based retrospective cohort studySemantic proximity Read

Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.Semantic proximity Read

The association between hepatic viral infections and cancers: A cross-sectional study in the Taiwan adult populationSemantic proximity Read

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.Semantic proximity Read

Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C StudySemantic proximity Read

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.Semantic proximity Read

Associations between serum levels of liver function biomarkers and all-cause and cause-specific mortality: A prospective cohort studySemantic proximity Read

Systematic analysis and prediction of the burden of Liver cancer due to hepatitis B in China and Global from 1990 to 2021Semantic proximity Read

Patients with COVID-19 and HBV Coinfection are at Risk of Poor PrognosisSemantic proximity Read